ASCO Tumor Boards: B Cell ALL CAR T Cell

Product ID : ATB1803
Price: $15.00
You will receive a link to your product from within 1 hour of purchase confirmation. Shipping charges do not apply to digital products.
E-mail to a friend



This is a case-based activity that includes a discussion of a nineteen-year-old male, who was previously in excellent health. While playing soccer he developed back pain. Over the course of several days, he noticed increasing fatigue, headaches and dizziness. He presented to the local Emergency Department for evaluation where his exam was notable for diffuse petechiae. Additional evaluation post lab results with a bone marrow demonstrated > 90% blasts. Flow cytometery confirmed a diagnosis of pre-B ALL with presence CD10+/CD19+/CD22+/TdT+ immunophenotypic markers.

At the end of this course, learners should be able to:

  • Describe the current status of CAR-T cell therapy for patients with Pre-B cell ALL
  • Discuss optimal timing of referral for patients to CAR-T Cell therapy
  • Examine limitations to CAR-T cell therapy

 IMPORTANT NOTE: This course expires on May 16, 2020. Participants must complete all necessary course components by this date.

Purchase the 2018 ASCO Tumor Boards Bundle and SAVE $25 to access to all six 2018 ASCO Tumor Boards.